| Fecal microbiota transplantation: current challenges and future landscapes A Yadegar, H Bar-Yoseph, TM Monaghan, S Pakpour, A Severino, ... Clinical microbiology reviews 37 (2), e00060-22, 2024 | 34 | 2024 |
| Future modulation of gut microbiota: from eubiotics to FMT, engineered bacteria, and phage therapy C Airola, A Severino, S Porcari, W Fusco, BH Mullish, A Gasbarrini, ... Antibiotics 12 (5), 868, 2023 | 28 | 2023 |
| The microbiome-driven impact of western diet in the development of noncommunicable chronic disorders A Severino, E Tohumcu, L Tamai, P Dargenio, S Porcari, D Rondinella, ... Best Practice & Research Clinical Gastroenterology, 101923, 2024 | 12 | 2024 |
| Antibiotic utilization in acute pancreatitis: a narrative review A Severino, S Varca, C Airola, T Mezza, A Gasbarrini, F Franceschi, ... Antibiotics 12 (7), 1120, 2023 | 12 | 2023 |
| Fecal Microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis S Porcari, A Severino, D Rondinella, S Bibbò, G Quaranta, L Masucci, ... Journal of Autoimmunity 141, 103033, 2023 | 10 | 2023 |
| Gut microbiota and immunotherapy of renal cell carcinoma S Bibbò, S Porcari, LE Del Vecchio, A Severino, BH Mullish, G Ianiro, ... Human vaccines & immunotherapeutics 19 (3), 2268982, 2023 | 7 | 2023 |
| LBA77 Fecal microbiota transplantation (FMT) versus placebo in patients receiving pembrolizumab plus axitinib for metastatic renal cell carcinoma: Preliminary results of the … C Ciccarese, S Porcari, S Buti, G Fornarini, F Primi, GC Giudice, ... Annals of Oncology 35 (Supplement 2), S1264-S1264, 2024 | 6 | 2024 |
| Gut microbiota in inflammation and colorectal cancer: A potential Toolbox for Clinicians N Grellier, A Severino, S Archilei, J Kim, A Gasbarrini, G Cammarota, ... Best Practice & Research Clinical Gastroenterology, 101942, 2024 | 2 | 2024 |
| “Pleiotropic” Effects of Antibiotics: New Modulators in Human Diseases C Airola, A Severino, I Spinelli, A Gasbarrini, G Cammarota, G Ianiro, ... Antibiotics 13 (12), 1176, 2024 | 1 | 2024 |
| The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier D Rondinella, PC Raoul, E Valeriani, I Venturini, M Cintoni, A Severino, ... Nutrients 17 (5), 859, 2025 | | 2025 |
| T. 06.8: A MICROBIOME TESTING-BASED PRECISION MEDICINE APPROACH TO TREAT POST-INFECTIOUS IRRITABLE BOWEL SYNDROME: A PILOT STUDY W Fusco, E Tohumcu, F Ocarino, F De Maio, T Rozera, S Porcari, ... Digestive and Liver Disease 56, S252, 2024 | | 2024 |
| OC. 04.6: SCREENING OF DONOR FECES WITH A DIRECT STOOL TESTINGBASED APPROACH: FRAMEWORK AND OUTCOMES OF A LARGEVOLUME DONOR STOOL BIOBANK FOR FECAL MICROBIOTA TRANSPLANTATION D Rondinella, G Quaranta, T Rozera, P Dargenio, G Fancello, ... Digestive and Liver Disease 56, S143-S144, 2024 | | 2024 |
| T. 06.3: PREVALENCE OF, AND MICROBIAL RISK FACTORS FOR, IRRITABLE BOWEL SYNDROME AND FUNCTIONAL DYSPEPSIA AFTER ACUTE GASTROINTESTINAL INFECTION: A SYSTEMATIC REVIEW AND META … S Porcari, MR Ingrosso, CJ Black, M Maida, LH Eusebi, M Fiorani, ... Digestive and Liver Disease 56, S248, 2024 | | 2024 |
| BOC. 02.1: EFFICACY AND SAFETY OF FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION: A 10-YEAR EXPERIENCE OF A LARGEVOLUME FMT CENTER G Ianiro, L Masucci, A Severino, M Fiorani, S Varca, S Porcari, S Bibbò, ... Digestive and Liver Disease 56, S108-S109, 2024 | | 2024 |
| BOC. 01.7: EFFICACY AND SAFETY OF FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATMENT OF SEVERE AND SEVERE-COMPLICATED CLOSTRIDIOIDES DIFFICILE INFECTION: REPORT FROM A LARGE … G Ianiro, L Masucci, A Severino, S Varca, M Fiorani, S Porcari, S Bibbò, ... Digestive and Liver Disease 56, S105, 2024 | | 2024 |
| T. 11.4: TARGETING THE INTESTINAL ECOSYSTEM THROUGH A GUT MICROBIOME TESTING TO TREAT RECURRENT URINARY-TRACT INFECTIONS FROM GUT PATHOBIONTS: A PILOT STUDY T Rozera, E Tohumcu, F Ocarino, F De Maio, S Porcari, M Fiorani, ... Digestive and Liver Disease 56, S278, 2024 | | 2024 |
| T. 03.10 HIGH RATE OF LATE REFERRAL AND DIAGNOSIS OF LIVER CIRRHOSIS DURING A FOUR-YEAR PERIOD IN A SECOND LEVEL MEDICAL CENTER: THE EXPERIENCE OF FONDAZIONE POLICLINICO GEMELLI MG Massaro, T Galasso, AL Monaco, R Maresca, V Ruggieri, A Severino, ... Digestive and Liver Disease 55, S149, 2023 | | 2023 |
